Summary: Defects in syrup caps lead to significant challenges for pharma companies, impacting multiple aspects of their operations. Additionally, regulatory risks become more prominent, as undetected defects can lead to non-compliance, fines, or even recalls. Pharma manufacturers can now leverage the SwitchOn DeepInspect® system to detect surface defects on syrup caps with an impressive 99.95% accuracy, ensuring superior product quality.